ADMA BIOLOGICS INC - COMMON STOCK

NetDania - New 12 months High: ADMA BIOLOGICS INC - COMMON STOCK

30 сен 2024 08:06:12 Источник NetDania Notify

ADMA Biologics Set to Join S&P SmallCap 600 Index

17 сен 2024 04:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference

10 сен 2024 04:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Partial Paydown of Revolving Credit Facility

14 авг 2024 05:59:22 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update

08 авг 2024 13:05:01 Источник Nasdaq GlobeNewswire

ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024

01 авг 2024 04:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update

09 май 2024 13:05:01 Источник Nasdaq GlobeNewswire

ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024

02 май 2024 04:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®

11 мар 2024 04:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

05 мар 2024 04:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces CFO Transition

28 фев 2024 13:10:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

28 фев 2024 13:05:00 Источник Nasdaq GlobeNewswire

ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

21 фев 2024 13:05:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics

21 фев 2024 04:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update

08 янв 2024 04:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management

18 дек 2023 13:05:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older

12 дек 2023 04:00:00 Источник Nasdaq GlobeNewswire

ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD

16 ноя 2023 04:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update

08 ноя 2023 13:05:01 Источник Nasdaq GlobeNewswire

ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023

01 ноя 2023 04:00:00 Источник Nasdaq GlobeNewswire